A simple and sensitive method for the determination of triptolide, wilforlide A and triptonide in human plasma was developed and validated, using high-performance liquid chromatography-electrospray ionization mass spectrometry (LC-ESI-MS). Plasma samples were purified using solid-phase extraction (SPE) columns. The HPLC separation of the analytes was performed on a MACHEREY-NAGEL C 18 column (2.0 mm؋125 mm, 3 m mm), using 2.7 mM formic acid containing 10 mM ammonium acetate-acetonitrile (55 : 45, v/v) as mobile phase, with a flow-rate of 0.25 ml/min. The compounds were ionized in the electrospray ionization (ESI) ion source of the mass spectrometer and were detected in the selected ion recording (SIR) mode. The calibration curves were linear in the 0.80-300 ng/ml range for all the three analytes, and the limits of detection were 0.25, 0.40, and 0.35 ng/ml for triptolide, wilforlide A, and triptonide, respectively. The average absolute recoveries for all the three analytes were above 81%. The methodology recoveries were greater than 91% and the relative standard deviations (RSD) of intra-day and inter-day were less than 15%. The developed method was successfully applied to the determination of triptolide, wilforlide A and triptonide concentration in patients' plasma after taking the medicament containing Tripterygium wilfordii HOOK. F.
Tripterygium wilfordii HOOK. F (TWHF), which is a perennial twining vine, grows densely on the shaded hill slopes in southern China. The extracts of the roots of the plant have been used in traditional Chinese medicine (named Lei-gongteng in Chinese) for the treatment of autoimmune disorders such as rheumatoid arthritis, systemic lupus erythematosus, and skin diseases for many years. 1, 2) A number of diterpenoids and triterpenoids have been isolated from Tripterygium wilfordii, 3, 4) some of them showed significant biological activities. For example, triptolide, wilforlide A, and triptonide ( Fig. 1 ) have potent antitumor, anti-inflammatory, immunosuppressive, and anti-fertility activities. 5) However, most of the terpenoids in Tripterygium wilfordii have a narrow therapeutic index [6] [7] [8] and some serious side effects. 9, 10) Therefore, accurate measurement of these terpenoids in blood samples is essential from a safety point of view.
Previous quantitative evaluations of these terpenoids have focused on triptolide in Tripterygium wilfordii and its ethyl acetate extracts. Analytical methods involved UV spectrophotometry, 11) thin layer chromatography, 12) HPLC with UV detection, 13, 14) and capillary electrophoresis. 15) Most of them, however, were developed for quantitative determination of triptolide in plants or medical preparations. There were fewer methods reported to be used in biological fluids.
Yang et al. developed a gas chromatography (GC) method 16) for the determination of triptolide in human plasma. Wang et al. developed an HPLC method 17) for the determination of triptolide and triptonide in human plasma. Although the published GC method 16) was sensitive (LLOQ: 1 ng/ml), it required derivatization for triptolide with trifluoroacetic anhydride and required laborious sample pretreatment, therefore it was not convenient for analysis of large numbers of samples. The HPLC method 17) was not sensitive enough (LLOQ: 10 ng/ml) to support the pharmacokinetic and toxicokinetic studies. Furthermore, the two methods needed a tediously long analysis time. 16, 17) The aim of this study is to develop a simple and selective high-performance liquid chromatography-electrospray ionization mass spectrometry (LC-ESI-MS) method for the determination of triptolide, wilforlide A and triptonide in human plasma. prepare series concentrations of working solutions just prior to use. The working solutions were spiked into drug-free human plasma samples to determine the recovery, precision and the limit of detection of LC-ESI-MS method. All these solutions had no change in stability over a period of 1 month tested.
MATERIALS AND METHODS

Equipment and Reagents
Chromatographic Conditions The analytes were separated on a MACHEREY-NAGEL C 18 column (2.0 mmϫ 125 mm, 3 mm, Germany) with column temperature 45°C. The mobile phase was 2.7 mM formic acid containing 10 mM ammonium acetate-acetonitrile (55 : 45, v/v) and was filtered through 0.45 mm filters in a solvent filtration apparatus and was never recirculated. The flow-rate was 0.25 ml/min, and the postcolumn splitting ratio was 3 : 1. ). Sample Preparation Fifty microliters of diazepam (I.S., 200 ng/ml) was added to the sample (0.5 ml). The sample was alkalinized by adding 0.1 ml sodium hydroxide (0.1 M). After vortex-mixed for 1.5 min and centrifuged at 9500 rpm for 5 min, the mixture was immediately loaded onto the Oasis TM HLB extraction cartridge, which had been activated with 1 ml of methanol and balanced with 1 ml of deionized water. The loaded plasma samples were drained away under vacuum (Ϫ40 kPa) and the columns were washed with 1 ml of ammonia in water (2%, v/v). The samples were subsequently eluted into glass with 1 ml of methanol containing 2% (v/v) acetic acid. The eluents were dried under nitrogen in a 40°C water bath. The residue was reconstituted in 0.1 ml of mobile phase. A volume of 20 ml sample was injected into the HPLC.
ESI-MS Detection Conditions
Sample cone and desolvation nitrogen were at the rate of 114 and 350 l/h, respectively. The capillary voltage was 3.90 kV. The sample cone voltage was 37, 35, 39, and 40 V for triptolide, wilforlide A, triptonide, and diazepam, respectively. Extractor voltage was 3.5
RESULTS AND DISCUSSION
LC-ESI-MS
The LC-ESI-MS in the SIR mode provided a highly selective method for the determination of triptolide, wilforlide A, and triptonide. The retention times of triptolide, wilforlide A, triptonide, and diazepam were approximately 5.8, 4.5, 6.9, and 9.8 min, respectively. The chromatograms of control human plasma, standards in control human plasma and patient samples were shown in Fig. 2 . ESI ϩ mass spectra (in the selected ion recording mode) of one patient plasma sample were illustrated in Fig. 3 . The protonated molecules [MϩH] ϩ were identified at m/z 361, 456, 359, and 286 for triptolide, wilforlide A, triptonide, and I.S., respectively.
Calibration Curves The calibration curve was constructed by adding 50 ml of I.S. and series concentrations of each analyte in blank human plasma. The concentration range was 0.80-300 ng/ml for the three analytes. The area ratio of each analyte to I.S. was well related to the concentration. The coefficients (r 2 ) for triptolide, wilforlide A, and triptonide were 0.9993, 0.9991, and 0.9994, respectively. Table 1 shows a summary of intra-and inter-day precision at three concentration levels (1.0, 100.0, 200.0 ng/ml) of triptolide, wilforlide A, and triptonide in plasma. Each concentration was detected in five consecutive days or five times in one day. Both intra-and inter-day RSDs were less than 15%. Results indicated that the present method has a satisfactory stability and reproducibility.
Precision and Recovery
The same three concentrations were used to determine methodology recovery. The results are summarized in Table  2 . The average methodology recoveries were higher than 91% for the analysts.
The absolute recoveries were determined at the same concentrations by comparing the analyte peak areas obtained from the quality control samples after extraction to those obtained from the corresponding unextracted reference standards prepared at the same concentrations. The results are summarized in Table 3 . The average absolute recoveries for all the three analytes were above 81%. The recovery of I.S. was 85.2% at the concentration used in the assay (200 ng/ml). Recovery of I.S. was consistent, precise and reproducible. Sensitivity The limits of quantitation (LOQ) were 0.80 ng/ml for the three analytes (S/Nϭ10). The limits of detection (LOD) were 0.25, 0.40, and 0.35 ng/ml for triptolide, wilforlide A, and triptonide, respectively (S/Nϭ3).
Analysis of Patient Plasma Plasma samples were obtained from 5 systemic lupus erythematosus schizophrenia patients (35Ϯ4 years old, female) after oral administration of Lei-gong-teng duo-dai tablets (a medicament made from Triptergium wilfordii) (200 mg each time, three times daily). The concentrations of triptolide, wilforlide A, and triptonide were determined by the LC-ESI-MS method, and the results are shown in Table 4 . Concentrations of triptolide, wilforlide A, and triptonide in these patients' plasma have obvious individual variation, so the therapeutic drug monitoring (TDM) is necessary to achieve the best therapeutic effects and the least toxicity.
CONCLUSION
An LC-ESI-MS method was developed for simultaneous determination of triptolide, wilforlide A, and triptonide in human plasma. The method is simple, accurate and sensitive. Thus, it is suitable for clinical and toxicological studies. 
